Oaktree Acquisition Corp. III Life Sciences posts preliminary redemption and sponsor conversion results
Oaktree Acquisition Corp. III Life Sciences reported 13.3 million Class A shares tendered for redemption and a sponsor conversion of 4.8 million Class B shares to Class A. Post-redemption and conversion, 11.3 million Class A and 1,000 Class B shares will remain. The sponsor will hold 5.4 million Class A and 1,000 Class B shares, with converted shares retaining certain restrictions.
